Wojciech Feleszko

Summary

Affiliation: Medical University of Warsaw
Country: Poland

Publications

  1. ncbi request reprint Synergistic interaction between highly specific cyclooxygenase-2 inhibitor, MF-tricyclic and lovastatin in murine colorectal cancer cell lines
    Wojciech Feleszko
    Department of Immunology, Centre of Biostructure Research, The Medical University of Warsaw, Poland
    Oncol Rep 9:879-85. 2002
  2. ncbi request reprint Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism
    Wojciech Feleszko
    Department of Immunology Center of Biostructure Research, The Medical University of Warsaw, Warsaw, Poland
    Int J Cancer 100:111-8. 2002
  3. ncbi request reprint Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice
    Adam Giermasz
    Department of Immunology, Centre for Biostructure Research, The Medical University of Warsaw, Poland
    Int J Cancer 97:746-50. 2002
  4. ncbi request reprint AAF-cmk sensitizes tumor cells to trail-mediated apoptosis
    Izabela Młnarczuk
    Department of Immunology, Center of Biostructure, The Medical University of Warsaw, Chalubinskiego 5, 02004 Warsaw, Poland
    Leuk Res 28:53-61. 2004
  5. ncbi request reprint Risk of allergy development correlates with IL-4 receptor expression on newborns' monocytes and Th lymphocytes
    Katarzyna Grzela
    Department of Pediatric Allergy and Pulmonology, Warsaw Medical University, Warsaw, Poland
    Med Sci Monit 13:CR445-8. 2007
  6. ncbi request reprint [Immune mechanisms in children with tuberculosis]
    Aleksandra Banaszkiewicz
    Klinika Pneumonologii, Chorób Alergicznych i Hematologii, Klinika Gastroenterologii i Zywienia Dzieci AM w Warszawie
    Pol Merkur Lekarski 15:203-7. 2003

Collaborators

  • Marek Jakobisiak
  • Tomasz Grzela
  • Dominika Nowis
  • Witold Lasek
  • Maciej Lazarczyk
  • Ahmad Jalili
  • Katarzyna Grzela
  • Izabela Młnarczuk
  • Jakub Gołąb
  • Cezary Wojcik
  • Aleksandra Banaszkiewicz
  • Adam Giermasz
  • Wiesława Sonczyk
  • Justyna Niderla-Bielińska
  • Grazyna Korczak-Kowalska
  • Wioletta Zagórska
  • Katarzyna Bocian
  • Marek Kulus
  • Urszula Jedrasiak
  • Anna Zawadzka-Krajewska
  • Grazyna Hoser
  • Paweł Mróz
  • Halina Ziemba
  • Łukasz P Biały
  • Jacek Malejczyk
  • Marcin Makowski
  • Ewa Kozłowska
  • Anna Dabrowska
  • Małgorzata Maj

Detail Information

Publications6

  1. ncbi request reprint Synergistic interaction between highly specific cyclooxygenase-2 inhibitor, MF-tricyclic and lovastatin in murine colorectal cancer cell lines
    Wojciech Feleszko
    Department of Immunology, Centre of Biostructure Research, The Medical University of Warsaw, Poland
    Oncol Rep 9:879-85. 2002
    ..5-fold in colon-26 cancer cells. Combination of a specific COX-2 inhibitor, MF-tricyclic, may increase antiproliferative effects of lovastatin in colon cancer cells and this effect was due to an augmented apoptosis...
  2. ncbi request reprint Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism
    Wojciech Feleszko
    Department of Immunology Center of Biostructure Research, The Medical University of Warsaw, Warsaw, Poland
    Int J Cancer 100:111-8. 2002
    ..The results of our studies suggest that lovastatin may enhance the effectiveness of chemotherapeutic agents in the treatment of malignant melanomas...
  3. ncbi request reprint Potentiating antitumor effects of a combination therapy with lovastatin and butyrate in the Lewis lung carcinoma model in mice
    Adam Giermasz
    Department of Immunology, Centre for Biostructure Research, The Medical University of Warsaw, Poland
    Int J Cancer 97:746-50. 2002
    ..Remarkably, a systemic treatment of syngeneic mice inoculated with 3LL cells with both drugs resulted in significant tumour growth retardation...
  4. ncbi request reprint AAF-cmk sensitizes tumor cells to trail-mediated apoptosis
    Izabela Młnarczuk
    Department of Immunology, Center of Biostructure, The Medical University of Warsaw, Chalubinskiego 5, 02004 Warsaw, Poland
    Leuk Res 28:53-61. 2004
    ..Altogether, our studies indicate that AAF-cmk might effectively sensitize human leukemia cells to apoptosis induced by TRAIL and TNF...
  5. ncbi request reprint Risk of allergy development correlates with IL-4 receptor expression on newborns' monocytes and Th lymphocytes
    Katarzyna Grzela
    Department of Pediatric Allergy and Pulmonology, Warsaw Medical University, Warsaw, Poland
    Med Sci Monit 13:CR445-8. 2007
    ..However, its role in allergy development remains unclear. The aim of this study was to assess the correlation between IL-4R expression and allergy development within the first year of life...
  6. ncbi request reprint [Immune mechanisms in children with tuberculosis]
    Aleksandra Banaszkiewicz
    Klinika Pneumonologii, Chorób Alergicznych i Hematologii, Klinika Gastroenterologii i Zywienia Dzieci AM w Warszawie
    Pol Merkur Lekarski 15:203-7. 2003
    ..The determinants have been shown of immune response against Mycobacteria with a special consideration of childhood Tbc...